Level C· Early human research exploring benefitsProspective StudyPubMed

Efficacy and Safety of Autologous Nanofat Injection in the Treatment of Postburn Scars Using Optical Skin Imaging Analysis.

Rageh MA., Fathi MK., Ibrahim SMA.

Prospective Study on Burns, Scar, published in Dermatol Surg (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Dermatol Surg (2024)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
39018082
DOI
10.1097/DSS.0000000000004322
Citations
2

Abstract (original English)

Background Burn scars are considered one of the challenging issues that can affect the quality of life by causing aesthetic and functional problems. Injecting nanofat particles, which are considered a source of stem cells, into the dermis and/or subcutis of the burned area is considered a promising procedure for the treatment of scars and the correction of volume shortage and skin renewal. Objective To assess the safety and effectiveness of using autologous nanofat injections to treat burn scars. Methods Thirty patients with postburn scars participated in the trial. Each patient received one session of liposuction, which was then converted into nanofat and injected back into the scar tissue. Four months after the session, the evaluation was conducted both objectively using the Antera camera 3D imaging and subjectively using the Vancouver scar scale (VSS). Results Because there were statistically significant improvements in the treated scars' height, color, vascularity, and pliability, the total VSS scores differed significantly before and after treatment. Furthermore, the Antera 3D imaging revealed a statistically significant variation in the treated scars' indentations, erythema, and pigmentation scores. Conclusion The study findings demonstrated that nanofat is a successful postburn scar treatment option that improves patients' quality of life.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansBurnsCicatrixFemaleMaleAdultTransplantation, AutologousMiddle AgedYoung AdultTreatment Outcome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research